IntraBio
This page is dedicated to news and information about IntraBio’s therapies for use in Niemann-Pick Disease Type C (NPC).
Information is released as it becomes available.
ABOUT INTRABIO GLOSSARY OF TERMS
IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of NPC
.
CLICK HERE FOR COMPLETE ANNOUNCEMENT
02/13/2019 jjb
IntraBio Receives Niemann-Pick Disease Orphan Drug Designation from the FDA for IB1000 Series
.
CLICK HERE FOR COMPLETE ANNOUNCEMENT
11/26/2018 jjb
